Stocks To Watch, February 13: Ola Electric, HUL, Torrent Pharma, Coal India, Mamaearth, Hindalco, HZL, IHCL, SpiceJet, Biocon

The state-owned Maharatna firm had reported a profit of ₹8,491 crore in the year-ago period.

Net sales dropped 5% YoY to ₹30,818 crore, while revenue from operations also declined 5% YoY to ₹34,924 crore.

The company's profit before tax (PBT) came in at ₹9,473 crore, down 20% YoY from ₹11,792 crore logged in the corresponding quarter of the previous fiscal year.

The Novelis aluminium plant in Oswego, New York, experienced two significant fires in the hot mill area on September 16, 2025, and November 21, 2025.

The airline had a profit of ₹24.97 crore in the December quarter of 2024, as per the standalone financial results submitted to the BSE.

These figures are loss and profit before tax.

Total income declined to ₹1,522.81 crore in the third quarter of the current financial year from ₹1,650.67 crore logged in the same period a year ago.

In a release, the airline said grounded fleet costs, higher ATF prices, rupee depreciation, and the one-time impact of the new labour laws pushed the airline's expenses higher in the December quarter.

The company's net profit stood at ₹632.53 crore during the corresponding period of the previous fiscal year, IHCL said in a statement.

The PAT was driven by the exceptional items, which mainly include profit on the sale of the entire equity stake in the joint venture company with the GVK group at ₹327 crore. There was also an impact on account of the New Labour Codes of ₹37 crore, IHCL Managing Director and CEO Puneet Chhatwal told PTI.

Revenue from operations of the company witnessed 12.19% growth at ₹2,841.96 crores during the quarter under review, compared with ₹2,533 crore in the same period of the previous year.

The Bengaluru-based firm posted a net profit of ₹25 crore for the same quarter of the last fiscal.

The revenue increased to ₹4,173 crore for the period under review against ₹3,821 crore in the year-ago period, the company said in a statement.

The company said its board has now granted in-principle approval to acquire the remaining 2% of Biocon Biologics Ltd's (BBL) paid-up equity share capital on a fully diluted basis from employees of the group.

The consideration for such acquisition of the BBL shares from the employees and other shareholders will be discharged by way of preferential allotment of the equity shares, it added.

The company registered a consolidated net loss of ₹38.92 crore in the year-ago period.

In a filing to BSE, the company said that its consolidated income dropped to ₹961.52 crore compared to ₹1,066.16 crore in the year-ago period.

In a statement, the company said, "The consolidated profit was at ₹8.07 crore in Q3 FY26."

The total expenses of the company declined to ₹985.98 crore from ₹1,309.89 crore in the year-ago period, the filing said.

The company said it has secured an order worth ₹577.89 crore from the Northeast Frontier Railway for the construction of four critical tunnels.

The company registered a net profit of ₹62.71 crore in the October-December period a year ago, according to a regulatory filing from Jagran Prakashan Ltd (JPL).

Its revenue from operations was down 7.7% to ₹476.71 crore in the December quarter. It was at ₹516.50 crore in the corresponding quarter a year ago.

JPL's total expenses were down 5.32% to ₹431.28 crore in the December quarter of FY26.

The total income of JPL, which includes other income, in the December quarter was down 6.16% to ₹504.50 crore.

It logged a profit of ₹26.02 crore in the October-December period a year ago, according to a regulatory filing.

Honasa Consumer's revenue from operations was up 16.23% to ₹601.54 crore in the December quarter of FY26. The revenue was at ₹517.51 crore in the corresponding quarter a year ago.

According to the company, the third-quarter revenue is "the highest-ever quarterly revenue for the company".

Total expenses of Honasa Consumer were at ₹550.31 crore, up 8.47%.

Its focus categories delivered growth of over 25%, driven by strong demand.

Net profit of ₹848 crore in October-December 2025 – the third quarter of the current 2025-26 fiscal year – compared with ₹806 crore earnings in the same period a year back, a company statement said.

The company, which operates two facilities at Dahej in Gujarat and Kochi in Kerala for the import of natural gas in its liquid form (LNG), saw overall volume throughput rise by 2% to 228 trillion British thermal units.

Net profit was ₹358.57 crore in October-December – the third quarter of the 2025-26 financial year – compared with ₹285.82 crore earnings in the same period of the previous fiscal year, the company said in a statement.

EBITDA per cubic metre of gas sold rose to ₹5.45 in Q3 from ₹4.29 a year back.

"IGL registered an overall sales volume growth of 3 per cent over the corresponding quarter in the last fiscal year, with the average daily sale going up from 9.11 million standard cubic metres per day to 9.43 mmscmd during the quarter," it said.

The company said its net profit stood at ₹361 crore for the October-December quarter of the last fiscal.

Revenue from operations rose to ₹1,724 crore for the third quarter as compared with ₹1,614 crore seen in the year-ago period, the drug firm said in a regulatory filing.

The company reported a net profit of ₹213 crore for the October-December quarter of the previous fiscal.

Revenue from operations increased to ₹4,343 crore for the third quarter against ₹3,475 crore in the year-ago period, Bharat Forge said in a regulatory filing.

The company said its board has declared an interim dividend of ₹2 per share.

"The second day of Bharat Heavy Electricals Limited OFS closed with an enthusiastic response from retail investors. The issue was subscribed 1.34 times," Department of Investment and Public Asset Management (DIPAM) Secretary Arunish Chawla said on X.

On Wednesday, institutional investors had placed bids for 22.07 crore BHEL shares at an indicative price of ₹256.07 a share, totalling over ₹5,650 crore.

It has received a Letter of Award (LOA) dated February 11, 2026, which was received by its arm Ceigall Infra Projects from the National Highways Authority of India (NHAI) to develop the project under the Hybrid Annuity Mode (HAM), the company said in an exchange filing.

The project involves the construction of four-laning of the Sahebganj–Areraj–Bettiah section of NH-139W, with a total length of 78.942 km, comprising Section 1: Sahebganj to Areraj (38.362 km) and Section 2: Areraj to Bettiah (40.580 km).

The bid project cost is approximately ₹2,160 crore, and the project will be executed under the Hybrid Annuity Model. The construction period is 730 days, followed by a 15-year operation and maintenance (O&M) period.

The drug firm reported a net profit of ₹132 crore for the October-December quarter of the last fiscal.

Revenue from operations rose to ₹647 crore for the period under review as compared with ₹475 crore in the year-ago period, Natco Pharma said in a regulatory filing.

The company said its board has declared a third interim dividend of ₹1.5 per share for the financial year 2025-26.

Besides, the company is also set to increase prices of the home care segment products, in which it operates with popular brands such as Surf Excel, Rin, Vim, and Domex in the detergent powder/liquid, dishwasher, and surface cleaner categories.

Crude oil prices have firmed up in recent weeks, while the rupee continues to depreciate, adding pressure on input costs across categories. Palm oil remains stable to inflation, said Gupta during the earnings calls.

Prices of sulphur and n-paraffins, which are the primary raw materials for home care products, are also rising.

In total, capital acquisition of military hardware worth ₹3.60 lakh crore, including procurement of an additional six US-made Boeing P8-I surveillance aircraft for the Indian Navy, was approved by the Defence Acquisition Council (DAC), chaired by Defence Minister Rajnath Singh.